应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02186 绿叶制药
休市中 08-21 16:08:08
2.160
+0.015
+0.70%
最高
2.315
最低
2.150
成交量
8,827万
今开
2.210
昨收
2.145
日振幅
7.69%
总市值
86.29亿
流通市值
86.29亿
总股本
39.95亿
成交额
1.94亿
换手率
2.21%
流通股本
39.95亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 绿叶制药(02186.HK)早盘涨超6% mRNA疫苗LY01620即将开展中国II期临床试验
智通财经 · 08-21 09:33
港股异动 | 绿叶制药(02186.HK)早盘涨超6% mRNA疫苗LY01620即将开展中国II期临床试验
绿叶制药:mRNA疫苗LY01620将开展中国II期临床试验
南方财经网 · 08-20 22:39
绿叶制药:mRNA疫苗LY01620将开展中国II期临床试验
绿叶制药公布治疗性HPV mRNA疫苗LY01620即将在华启动II期临床
公告速递 · 08-20 22:35
绿叶制药公布治疗性HPV mRNA疫苗LY01620即将在华启动II期临床
绿叶制药(02186)拟于8月29日召开董事会审议2026年中期业绩
公告速递 · 08-17
绿叶制药(02186)拟于8月29日召开董事会审议2026年中期业绩
绿叶制药2026年7月股份变动月报:股本保持稳定
公告速递 · 08-06
绿叶制药2026年7月股份变动月报:股本保持稳定
绿叶制药创新药LY03015美国桥接试验完成 安全耐受性高加索组优于中国组
公告速递 · 08-05
绿叶制药创新药LY03015美国桥接试验完成 安全耐受性高加索组优于中国组
绿叶制药:创新药LY03015在美完成桥接临床试验
南方财经网 · 08-05
绿叶制药:创新药LY03015在美完成桥接临床试验
异动解读|绿叶制药盘中下跌5.41%,报2.09港元
行情直击 · 07-17
异动解读|绿叶制药盘中下跌5.41%,报2.09港元
异动解读|绿叶制药盘中上涨6.45%,可转债赎回叠加创新药临床利好持续推升
行情直击 · 07-15
异动解读|绿叶制药盘中上涨6.45%,可转债赎回叠加创新药临床利好持续推升
异动解读|绿叶制药盘中上涨5.29%,可转债赎回叠加临床利好持续提振
行情直击 · 07-14
异动解读|绿叶制药盘中上涨5.29%,可转债赎回叠加临床利好持续提振
异动解读|绿叶制药盘中上涨5.73%,多重利好共振提振市场情绪
行情直击 · 07-13
异动解读|绿叶制药盘中上涨5.73%,多重利好共振提振市场情绪
创新药板块走低 科伦博泰生物(06990)跌7.67% 当前板块仍处估值修复行情
金吾财讯 · 07-08
创新药板块走低 科伦博泰生物(06990)跌7.67% 当前板块仍处估值修复行情
绿叶制药(02186)完成提前赎回未清偿的1.8亿美元6.25%利率2028年到期可转换债券
智通财经 · 07-06
绿叶制药(02186)完成提前赎回未清偿的1.8亿美元6.25%利率2028年到期可转换债券
绿叶制药更新6月股份变动月报表,股本维持稳定
公告速递 · 07-06
绿叶制药更新6月股份变动月报表,股本维持稳定
【券商聚焦】招商证券维持绿叶制药(02186)“强烈推荐”评级 指LY03015临床结果积极
金吾财讯 · 07-06
【券商聚焦】招商证券维持绿叶制药(02186)“强烈推荐”评级 指LY03015临床结果积极
异动解读|绿叶制药盘中上涨5.91%,获瑞银增持叠加创新药板块整体回暖
行情直击 · 07-03
异动解读|绿叶制药盘中上涨5.91%,获瑞银增持叠加创新药板块整体回暖
异动解读|绿叶制药盘中下跌6.91%,创新药板块持续承压回调
行情直击 · 06-30
异动解读|绿叶制药盘中下跌6.91%,创新药板块持续承压回调
绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)治疗迟发性运动障碍的中国Ⅱ期临床研究取得积极结果
智通财经 · 06-16
绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)治疗迟发性运动障碍的中国Ⅱ期临床研究取得积极结果
绿叶制药(02186)完成发行1.8亿美元5.25%利率2031年到期可转换债券
智通财经 · 06-11
绿叶制药(02186)完成发行1.8亿美元5.25%利率2031年到期可转换债券
港股午评|恒生指数早盘跌1.4% 半导体逆市走高
智通财经 · 06-04
港股午评|恒生指数早盘跌1.4% 半导体逆市走高
加载更多
公司概况
公司名称:
绿叶制药
所属市场:
SEHK
上市日期:
--
主营业务:
绿叶制药集团有限公司是一家主要从事药品的开发、生产、推广及销售的公司。该公司经营四个分部,包括肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和中枢神经系统药物分部。肿瘤药物分部提供力扑素、博优诺、百拓维、希美纳及米美欣等药品。心血管系统药物分部提供血脂康、欧开及麦通纳等药品。消化与代谢药物分部提供贝希等药品。中枢神经系统药物分部提供思瑞康、若欣林、瑞可妥、美比瑞及金悠平等药品。
发行价格:
--
{"stockData":{"symbol":"02186","market":"HK","secType":"STK","nameCN":"绿叶制药","latestPrice":2.16,"timestamp":1787299688003,"preClose":2.145,"halted":0,"volume":88265500,"delay":0,"changeRate":0.006993006993007051,"floatShares":3995000000,"shares":3995000000,"eps":0.1853285784096166,"marketStatus":"休市中","change":0.015,"latestTime":"08-21 16:08:08","open":2.21,"high":2.315,"low":2.15,"amount":194019102,"amplitude":0.076923,"askPrice":2.165,"askSize":129500,"bidPrice":2.16,"bidSize":268500,"shortable":3,"etf":0,"ttmEps":0.1853285784096166,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1404835200000,"exchange":"SEHK","adjPreClose":2.145,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":2.5104716350878267,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02186","defaultTab":"news","newsList":[{"id":"2661256891","title":"港股异动 | 绿叶制药(02186.HK)早盘涨超6% mRNA疫苗LY01620即将开展中国II期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256891","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661256891?lang=zh_cn&edition=full","pubTime":"2026-08-21 09:33","pubTimestamp":1787275991,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1606","BK1583","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660923801","title":"绿叶制药:mRNA疫苗LY01620将开展中国II期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2660923801","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660923801?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:39","pubTimestamp":1787236740,"startTime":"0","endTime":"0","summary":"南财智讯8月20日电,绿叶制药(02186.HK)发布自愿公告,公告基本信息:公司于2026年8月20日发布自愿性公告,宣布自主研发的治疗性mRNA疫苗LY01620即将在中国开展II期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608203848182093.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608203848182093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MRNY","BMED","IBBJ","MRNX","BK1606","IBBQ","BK1583","PSYK","02186","BK1191","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104812966","title":"绿叶制药公布治疗性HPV mRNA疫苗LY01620即将在华启动II期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=1104812966","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104812966?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:35","pubTimestamp":1787236532,"startTime":"0","endTime":"0","summary":"2026年8月20日,绿叶制药集团有限公司发布自愿性公告称,其自主研发的治疗性信使核糖核酸疫苗LY01620即将在中国开展II期临床试验。本次II期研究计划招募经组织学确诊的HPV16阳性子宫颈高级别鳞状上皮内病变患者,以进一步评估该产品的有效性和安全性。公司表示,LY01620有望填补HPV治疗性疫苗市场空白,并正积极探索其在其他HPV相关实体肿瘤中的临床应用。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134431558","title":"绿叶制药(02186)拟于8月29日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1134431558","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134431558?lang=zh_cn&edition=full","pubTime":"2026-08-17 22:05","pubTimestamp":1786975531,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司(02186)8月17日发布公告称,公司董事会已订于2026年8月29日(星期六)召开会议,届时将审议截至2026年6月30日止六个月的中期业绩及其发布事宜,并考虑派发中期股息(如有)。\\n\\n根据公告,此次会议议程重点包括:1)批准公司及其附属公司2026年中期财务报告;2)就派发中期股息(如有)进行讨论与决定。\\n\\n公告同时列出了公司现任董事会成员,包括执行董事刘殿波、杨荣兵、袁会先、祝媛媛;非执行董事宋瑞霖、黄立明;以及独立非执行董事张化桥、卢毓琳、梁民杰、蔡思聪、夏莲。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116072707","title":"绿叶制药2026年7月股份变动月报:股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1116072707","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116072707?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:38","pubTimestamp":1786005501,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司于2026年8月6日发布2026年7月股份变动月报表。根据公告,截至2026年7月31日,公司法定注册股本总额维持在100亿股,普通股每股面值0.02美元,注册股本保持2亿美元,上月底与本月底相比未发生增减变化。公司在7月无新增发行、购回或注销股份,股本总量保持不变。在可换股票据方面,公司原有的于2028年到期、金额为1.8亿美元的6.25%可换股债券,期初余额为9,026万美元,已于2026年7月6日全部赎回并注销。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136715832","title":"绿叶制药创新药LY03015美国桥接试验完成 安全耐受性高加索组优于中国组","url":"https://stock-news.laohu8.com/highlight/detail?id=1136715832","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136715832?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:06","pubTimestamp":1785935160,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司(02186)8月5日公告,其自主研发的新分子实体LY03015已在美国成功完成桥接临床试验,为即将在美国开展的疗效临床试验提供支持。该试验发现,高加索人群较中国人群表现出更好的安全耐受性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547479","title":"绿叶制药:创新药LY03015在美完成桥接临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547479","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657547479?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:05","pubTimestamp":1785935100,"startTime":"0","endTime":"0","summary":"南财智讯8月5日电,绿叶制药(02186.HK)发布自愿公告,公司自主研发的创新药LY03015(VMAT2抑制剂/Sigma-1R激动剂)在美国成功完成桥接临床试验,支持其即将开展的美国疗效临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832810135.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832810135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PSYK","IBBJ","MEDX","BK1191","06978","BK1574","LNGR","MDTX","BK1583","BK1161","BMED","BK1606","IBBQ","02186","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184468537","title":"异动解读|绿叶制药盘中下跌5.41%,报2.09港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184468537","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184468537?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:41","pubTimestamp":1784256076,"startTime":"0","endTime":"0","summary":"7月17日,绿叶制药盘中下跌5.41%,报2.09港元/股,成交额5199.23万港元。绿叶制药所在的制药行业中,整体表现疲弱,个股中,石药集团跌5.93%,中国生物制药跌5.7%,翰森制药跌4.04%,恒瑞医药跌4.83%,凯莱英跌8.39%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100429752","title":"异动解读|绿叶制药盘中上涨6.45%,可转债赎回叠加创新药临床利好持续推升","url":"https://stock-news.laohu8.com/highlight/detail?id=1100429752","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100429752?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:49","pubTimestamp":1784080143,"startTime":"0","endTime":"0","summary":"7月15日,绿叶制药盘中上涨6.45%,报2.27港元,成交额7007.71万港元,连续三个交易日走强。此外,公司创新药LY03015治疗迟发性运动障碍的中国II期临床达到主要终点,最高剂量组应答率达76.5%,接近现有一线药物历史数据的两倍,公司计划推进中美III期临床。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182535620","title":"异动解读|绿叶制药盘中上涨5.29%,可转债赎回叠加临床利好持续提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1182535620","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182535620?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:15","pubTimestamp":1783995326,"startTime":"0","endTime":"0","summary":"7月14日,绿叶制药盘中上涨5.29%,报2.19港元,成交额9422.62万港元。消息面上,公司近期利好密集释放。7月6日,公司完成提前赎回全部未清偿的1.8亿美元6.25%利率2028年到期可转换债券,所有债券已赎回并注销,有效消除潜在股权稀释压力。同时,公司此前已完成发行1.8亿美元5.25%利率2031年到期新可转换债券,成功实现债务置换并将融资成本降低100个基点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111370535","title":"异动解读|绿叶制药盘中上涨5.73%,多重利好共振提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1111370535","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111370535?lang=zh_cn&edition=full","pubTime":"2026-07-13 10:10","pubTimestamp":1783908601,"startTime":"0","endTime":"0","summary":"7月13日,绿叶制药盘中上涨5.73%,报2.03港元,成交额5635.49万港元。消息面上,公司近期利好密集释放。7月6日,公司完成提前赎回全部未清偿的1.8亿美元6.25%利率2028年到期可转换债券,所有债券已赎回并注销,有效消除了潜在的股权稀释压力。此外,公司已于6月完成发行1.8亿美元5.25%利率2031年到期新可转换债券,成功实现债务置换并降低融资成本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649954218","title":"创新药板块走低 科伦博泰生物(06990)跌7.67% 当前板块仍处估值修复行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2649954218","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649954218?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:08","pubTimestamp":1783480087,"startTime":"0","endTime":"0","summary":"有研究指,创新药板块年内曾两轮短期反弹,本轮行情依托政策组合、高含金量海外交易、机构持续加仓三大不同支撑,但机构表示当前仅为估值修复行情,基本面全面反转仍需中期、三季度财报验证,后续走势重点跟踪企业盈利兑现与CGT正式政策落地进度。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985359","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","LU0979878070.USD","LU2476274308.USD","09926","06855","LU0819121731.USD","BK1191","IBBQ","LU1046422090.SGD","SG9999014674.SGD","06978","06990","KURE","LU0417516571.SGD","LU0140636845.USD","SG9999002463.SGD","LU0051755006.USD","LU0456846285.SGD","02359","01672","02268","06955","CZA","BK1515","LU0588546209.SGD","LU2242644610.SGD","LU3063872942.SGD","BK1600","LU0348784397.USD","REVS","LU0326950275.SGD","BK1521","00460","01530","BK1583","LU0516422440.USD","02186","LU0196878994.USD","MEDX","LU0516423091.SGD","02269","01952","LU0320764599.SGD","LU0348783233.USD","01477","LU1880383366.USD","LU0052750758.USD","BK1141","IE00B0JY6N72.USD","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649622541","title":"绿叶制药(02186)完成提前赎回未清偿的1.8亿美元6.25%利率2028年到期可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2649622541","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649622541?lang=zh_cn&edition=full","pubTime":"2026-07-06 21:38","pubTimestamp":1783345102,"startTime":"0","endTime":"0","summary":"本公司已收到赎回通知,要求本公司赎回全部未清偿债券,本金总额为9026万美元。截至本公告日期,提前赎回已完成且所有未清偿债券均已赎回并注销,故并无任何发行在外的未清偿债券。撤销债券的上市地位预期将于2026年7月15日营业时间结束后生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02186","UBmain","BK1191","TNmain","ZBmain","ZFmain","CVRT","BK1606","ZNmain","BK1583","ZTmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102056370","title":"绿叶制药更新6月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1102056370","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102056370?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:50","pubTimestamp":1783327819,"startTime":"0","endTime":"0","summary":"绿叶制药于2026年7月6日发布截至2026年6月30日的月报表。报告显示,公司注册股本维持在10,000,000,000股,面值每股0.02美元,总额2亿美元;已发行股份总数仍为3,994,515,953股,期内无新增发行、购回或库藏股变动。根据披露,公司本月未发生已发行股份数量的变化。截至本月末,公司股本结构整体维持稳定,并确认已符合香港联合交易所有限公司相关上市规则及法律法规的要求。公告由公司董事祝媛媛签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649641723","title":"【券商聚焦】招商证券维持绿叶制药(02186)“强烈推荐”评级 指LY03015临床结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2649641723","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649641723?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:41","pubTimestamp":1783323680,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招商证券发布研报指,绿叶制药 自主研发的1类创新药LY03015治疗迟发性运动障碍的中国II期临床试验取得积极结果,达到主要终点。研报认为,LY03015的II期临床结果初步验证了其治疗TD的有效性和安全性,未发生与药物相关的严重不良事件,常见不良事件多为轻中度且基本能痊愈或好转。基于此积极结果,公司将快速推进LY03015的中美III期临床研究。维持绿叶制药“强烈推荐”投资评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985199","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","KCE","06099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121224064","title":"异动解读|绿叶制药盘中上涨5.91%,获瑞银增持叠加创新药板块整体回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=1121224064","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121224064?lang=zh_cn&edition=full","pubTime":"2026-07-03 10:06","pubTimestamp":1783044361,"startTime":"0","endTime":"0","summary":"7月3日,绿叶制药盘中上涨5.91%,报1.95港元/股,成交额7724.88万港元。消息面上,据联交所披露文件,UBS Group AG于6月22日增持绿叶制药约3398万股,好仓比例由13.22%升至14.07%,最新持股约5.62亿股。同时,创新药板块在前期大幅回调后迎来整体反弹,同行业中翰森制药涨6.51%、石药集团涨4.64%、中国生物制药涨2.81%,板块资金回流明显。此前绿叶制药核心管线LY03015中国Ⅱ期临床达主要终点,最高剂量组应答率达76.5%,计划推进中美Ⅲ期临床。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173396501","title":"异动解读|绿叶制药盘中下跌6.91%,创新药板块持续承压回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1173396501","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173396501?lang=zh_cn&edition=full","pubTime":"2026-06-30 10:53","pubTimestamp":1782788025,"startTime":"0","endTime":"0","summary":"6月30日,绿叶制药盘中下跌6.91%,报1.75港元/股,成交额1.07亿港元。消息面上,创新药板块近期持续调整,恒生港股通创新药指数已回落至去年板块大涨前水平,多家药企承压明显。绿叶制药此前因核心管线LY03015二期临床数据积极一度涨超7%,但该利好已于6月17日释出,近期股价持续回吐涨幅。同行业中,石药集团跌1.54%,恒瑞医药跌1.63%,中国生物制药跌1.56%,翰森制药跌2.64%,凯莱英跌5.01%,板块整体偏弱。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643763638","title":"绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)治疗迟发性运动障碍的中国Ⅱ期临床研究取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2643763638","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643763638?lang=zh_cn&edition=full","pubTime":"2026-06-16 22:20","pubTimestamp":1781619613,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,集团自主研发的1类创新药LY03015用于治疗迟发性运动障碍的中国Ⅱ期临床试验已完成,取得积极结果,达到主要终点。LY03015为全球首个进入临床的囊泡单胺转运体2和Sigma-1R双靶点创新药,目标适应症为TD和亨廷顿病相关的舞蹈症。集团通过自主建立的AI药物设计平台,设计了全新结构的小分子药物LY03015,不仅解决了上述安全性风险,而且高活性靶向VMAT2和Sigma-1R,发挥“症状控制”和“病理改善”的双重作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","BK1606","BK1574","06978","159992","02186","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642474015","title":"绿叶制药(02186)完成发行1.8亿美元5.25%利率2031年到期可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2642474015","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642474015?lang=zh_cn&edition=full","pubTime":"2026-06-11 08:02","pubTimestamp":1781136158,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药(02186)发布公告,认购协议所载发行债券的所有先决条件均已获达成,且认购及发行本金总额为1.8亿美元的债券已于2026年6月10日完成。该等债券已于2026年6月10日在维也纳证券交易所上市。每股转换股份的初步换股价为2.71港元,较:股份于2026年6月3日(即签署认购协议的交易当日)在联交所所报收市价2.170港元溢价约24.9%;及股份于直至2026年6月2日(包括该日)止最后五个连续交易日在联交所所报收市价的平均价每股2.184港元溢价约24.1%。转换股份上市及买卖批准已获联交所授予。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ZTmain","TNmain","ZBmain","02186","ZNmain","BK1606","BNDW","BK1191","ZFmain","UBmain","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640139070","title":"港股午评|恒生指数早盘跌1.4% 半导体逆市走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2640139070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640139070?lang=zh_cn&edition=full","pubTime":"2026-06-04 12:00","pubTimestamp":1780545643,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数跌1.4%,跌358点,报25274点;恒生科技指数跌1.43%。港股早盘成交1438亿港元。兆易创新逆市涨超9%,首季度全球NAND市场规模环比接近翻倍,机构指利基存储将全面涨价。中兴通讯 涨4.3%,与腾讯达成深度战略合作,双方即将重磅发布WorkBuddy AI云电脑。有色股集体承压。能源涨价推高通胀水平,美联储加息预期走高。洛阳钼业跌5.7%;五矿资源跌4.4%。黄金股跌幅居前,高油价推高通胀预期,多家大行同时下调金价预测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0737861772.HKD","LU1023057109.AUD","SG9999017495.SGD","SGXZ90724238.SGD","LU0878004406.USD","BK1198","LU0516422440.USD","LU2106854487.HKD","LU2213484517.USD","BK1529","LU1051768304.USD","LU1794554557.SGD","LU2362540622.SGD","LU2237443622.USD","LU0588546209.SGD","LU0048580855.USD","LU0516422366.SGD","LU1282649141.HKD","BK1594","LU2251237488.HKD","BK1516","IE00B0169L03.USD","ZIJMY","01347","LU0856984785.SGD","LU0675040207.SGD","LU1691799644.USD","LU0577902611.USD","LU1515016050.SGD","LU1316542783.SGD","LU0823040885.USD","LU0244354667.USD","LU1769817179.HKD","LU0650527681.SGD","LU0049853897.USD","LU1048596156.SGD","LU0117841782.USD","IE00B8HQ1Z84.USD","LU1064130708.USD","TCEHY","SG9999004311.SGD","LU0633140727.USD","IE00BZ08YT58.USD","LU0287142896.SGD","688347","LU0320764599.SGD","BK1506","SG9999018865.SGD","LU2778985437.USD","LU1804176565.USD","LU0228659784.USD","LU0823038988.USD","01208","HSI","LU0143863784.USD","IE00BGV7N243.SGD","BK1608","LU0328353924.USD","SG9999002463.SGD","SG9999004220.SGD","LU0463099449.HKD","SG9999014914.USD","LU0455707207.USD","LU0823397103.USD","IE0032431581.USD","LU0348814723.USD","LU0469268626.HKD","LU2177674079.SGD","02577","LU0359202008.SGD","LU1044876610.USD","IE0003851619.USD","LU0061477393.USD","LU1961090484.USD","02186","LU0329678337.USD","BK1170","LU0293314216.USD","LU0345780521.USD","LU1226288170.HKD","LU2087589342.USD","SG9999013353.USD","LU2097828805.USD","BK1615","IE00B0169N27.USD","LU2187417386.USD","IE00BQXX3D17.EUR","LU0708995153.HKD","LU0048388663.USD","LU1226287529.USD","LU1226287875.USD","SG9999002828.SGD","LU2097828631.EUR","07200","LU2045819591.USD","LU0164939612.USD","LU0211977185.USD","LU2265009873.SGD","SG9999001051.SGD","LU2237443978.SGD","LU0210526637.USD","LU1880383440.USD","LU0414403682.SGD","LU1323998911.USD","LU1282649810.SGD","LU2476274720.SGD","TCHmain","LU0345769128.USD","BK1502","LU1883866441.USD","LU2351347302.SGD","LU1974910355.USD","LU1688375341.USD","LU1044875133.USD","LU1993786604.SGD","LU1366334578.USD","SG9999000327.SGD","LU0039217434.USD","LU0210527791.USD","LU1951186391.HKD","LU1242518931.SGD","LU0543330483.HKD","02833","IE00B29SXG58.USD","LU0117844026.USD","LU1568876335.HKD","LU0797268264.HKD","LU1960683339.HKD","LU0348827113.USD","SG9999001226.SGD","HK0000151867.HKD","LU1733274473.HKD","LU2023250504.SGD","LU0345775950.USD","LU0862451837.USD","LU0499858438.USD","LU2462611646.USD","BK1618","BK1163","SG9999002562.SGD","LU1719994722.HKD","LU1770034418.SGD","IE0008368411.USD","LU0737861699.HKD","LU1629966141.USD","688234","LU0541501648.USD","MCHmain","83115","LU0880133367.SGD","LU0054450605.USD","BK1149","LU0572939691.SGD","LU1831875114.USD","IE00BZ08YS42.EUR","LU1282651048.USD","LU1439102457.SGD","02899","LU1642822792.SGD","BK1606","LU0985320562.USD","LU0449515922.USD","LU0384037296.USD","LU0683595622.HKD","LU0541502299.USD","SG9999014898.SGD","LU0314109678.HKD","LU0823413660.USD","LU0181495838.USD","LU0345780281.USD","LU1868838027.USD","LU0214875030.USD","IE00B8L5B284.USD","LU0878005551.USD","SG9999018857.SGD","82800","HK0000306685.HKD","LU0572944931.SGD","LU0261947096.USD","BK1505","LU0164865239.USD","LU0791590937.USD","LU0786609619.USD","LU1064131342.USD","LU0509642566.USD","LU0605514214.HKD","LU1880383366.USD","LU2125910500.SGD","LU2264538146.SGD","LU0348783233.USD","LU0082770016.SGD","IE0003895053.USD","LU1813983027.USD","LU1224709979.USD","LU0651946864.USD","LU1303224171.USD","00700","LU0873338254.USD","LU1226288253.USD","601899","HK0000352382.USD","00189","LU0307460666.USD","HK0000320264.USD","LU0048597586.USD","BK1586","LU0096374516.USD","LU0067412154.USD","03993","IE00B97KM107.HKD","LU0107464264.USD","LU0143863198.USD","LU0231483743.USD","LU0084288322.USD","LU0828238088.HKD","LU0791591158.USD","LU1810669033.SGD","BK1191","LU2257852520.SGD","SG9999015986.USD","LU0326948709.USD","GB00BDT5M118.USD","LU1008478684.HKD","LU0254981946.USD","LU1770036033.HKD","LU0266512127.USD","LU0052750758.USD","LU0051755006.USD","LU0456854461.SGD","LU2449936058.SGD","LU1733274390.USD","LU0784639295.USD","LU1988902786.USD","LU1328615791.USD","LU1808992512.USD","LU0531970944.HKD","LU1226288097.SGD","LU1868837722.USD","SG9999007991.SGD","LU0327786744.USD","IE0031814852.USD","BK1526","LU1956131251.USD","LU0029875118.USD","BK1607","LU0203347892.USD","LU0577902538.SGD","LU1718418525.SGD","LU0979878070.USD","LU0054237671.USD","LU0648948544.HKD","IE0032834883.USD","LU1044874839.SGD","LU0516422952.EUR","HTCD.SI","HK0000352291.HKD","IE0034224299.USD","LU0886674414.USD","LU0607220059.USD","LU2051468812.USD","LU2226246903.HKD","IE00BQXX3C00.GBP","LU0106959298.USD","LU2251237306.USD","IE00B031HW06.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU2125910849.SGD","LU0531971595.HKD","LU0163747925.USD","LU2476274308.USD","LU0823426480.USD","LU1152091168.USD","LU0080751232.USD","LU1188198961.HKD","LU0269904917.USD","LU0672654166.SGD","LU0488056044.USD","LU1046422090.SGD","LU0823426308.USD","LU1048588211.SGD","LU2237443465.HKD","LU1282651121.HKD","BK1589","LU0823397285.USD","LU0348825331.USD","LU0326950275.SGD","LU0608807433.USD","LU0196878994.USD","LU0169518387.USD","HK0000914686.HKD","LU1439103000.SGD","LU1282648689.USD","LU0633140560.USD","LU0165289439.USD","SG9999014674.SGD","SG9999015978.USD","09115","LU0348723411.USD","LU0577902371.SGD","LU0572940350.SGD","LU0865486749.SGD","LU0594300179.USD","IE0001KFT4U8.USD","LU0070217475.USD","LU0266512473.USD","LU0128522157.USD","LU0634319403.HKD","LU0516423091.SGD","SG9999015952.SGD","IE0009570106.USD","02553","SG9999015945.SGD","LU0642271901.SGD","LU0173614495.USD","LU0620787316.HKD","IE0003795394.USD","BK1609","LU0823413587.USD","LU1734074674.USD","513600","LU0828237510.HKD","LU0164880469.USD","LU1196710195.USD","LU0203345920.USD","LU0345776255.USD","SG9999014880.SGD","LU2237443382.USD","IE00B3M56506.USD","LU0561508036.HKD","LU1769817096.USD","IE00B031HY20.USD","02631","LU1981816686.USD","LU2242644610.SGD","LU0211331839.USD","LU0431992006.USD","LU2039709279.SGD","07300","BK1517","LU0651947912.USD","LU0315178854.USD","LU3063872942.SGD","LU1868837565.USD","IE00B031J352.USD","LU1504937902.USD","BK1129","SGXZ51526630.SGD","LU0082770016.USD","LU0456846285.SGD","LU2399975544.HKD","LU2929501877.USD","LU2133065610.SGD","LU0862451753.SGD","LU2293587155.HKD","LU1807302812.USD","LU0819123356.HKD","BK1583","LU0543330566.HKD","00894","LU2279701549.SGD","SG9999000418.SGD","LU0449509016.USD","03419","03037","LU0261950983.USD","HHImain","HK0001040168.HKD","LU0192582467.USD","LU0320764243.SGD","603993","LU0890818403.SGD","LU1152091754.HKD","SG9999001689.USD","IE0008369823.USD","LU2498475776.HKD","HSTECH","LU0828237940.HKD","LU2097828474.EUR","IE00B5MMRT66.SGD","LU0072462343.USD","HK0000306701.USD","LU0251144936.SGD","SG9999001093.SGD","LU0329678170.USD","LU0499858602.USD","LU0228367735.SGD","LU2008162690.USD","LU2148510915.USD","LU0235996351.USD","LU0918141887.USD","HK0000320223.HKD","LU0577902454.USD","BK1095","LU2294711473.HKD","LU2097828557.USD","LU0348816934.USD","LU0589944569.HKD","SG9999006514.SGD","LU2247934214.USD","LU0417516738.SGD","SGXZ99366536.SGD","07500","LU0823041008.USD","LU1366334651.USD","LU0823039010.USD","LU0502904849.HKD","LU1242518857.USD","JINFF","IE00BPRC5H50.USD","LU0229945570.USD","LU0821914370.USD","LU1235295612.USD","SGXZ31699556.SGD","LU0106259558.USD","LU0819121731.USD","HK0000914660.USD","LU0315179316.USD","LU0127658192.USD","02800","LU1568876251.USD","IE00B543WZ88.USD","LU1785774172.SGD","LU0577902298.EUR","LU1102505762.USD","LU0456827905.SGD","LU1115378108.SGD","BK1169","LU0396098781.USD","LU0611395673.USD","LU0049112450.USD","LU0011963245.USD","LU1051769294.HKD","LU0501845795.SGD","LU0738912210.USD","LU0456842615.SGD","LU0128522744.USD","LU0140636845.USD","LU0871576103.HKD","LU0417516902.SGD","LU0348788117.USD","LU1675838814.USD","LU0540923850.HKD","LU2097828714.EUR","IE00B0JY6N72.USD","SG9999001069.SGD","LU2362541513.USD","BK1544","IE00B067MR52.USD","HK0001040143.USD","LU0164872284.USD","LU0831103253.SGD","LU1224444064.USD","LU0417516571.SGD","LU2237443549.SGD","LU1102505929.USD","LU0264606111.USD","LU0149721374.USD","LU0348784397.USD","03986","LU0259732245.USD","SG9999006597.SGD","SG9999014906.USD","LU2152927971.USD","LU0348783662.USD","BK1511","LU0640798160.USD","LU0898667661.SGD","LU0593848301.USD","LU0868486357.SGD","LU1481107354.HKD","LU0175139822.USD","BK1592","LU2362541273.HKD","LU1064131003.USD","LU0359201612.USD","LU1917777945.USD","LU0132412106.USD","LU1725190679.HKD","LU1251922891.USD","LU0441854154.USD","LU0359201885.HKD","BK1610","SG9999003461.SGD","LU0345769631.USD","LU0149534421.HKD","IE0008368742.USD","LU0106252389.USD","LU0370786039.SGD","LU1196710864.SGD","LU0043850808.USD","LU0588545730.USD","02099","LU1048484197.HKD","SG9999001846.SGD","LU1196710351.USD","LU1814569148.SGD","LU0594300419.USD","BK1614","LU0210533765.USD","LU0588545904.SGD","LU0029874905.USD","LU0320764755.SGD","LU1211504680.USD","BK1522","LU1655091459.SGD","000063","LU0700851271.USD","LU2317271919.USD","BK1531","IE00BF5LJ272.USD","LU1105468828.SGD","SGXZ81514606.USD","BK1591","LU1226287792.SGD","LU0918141705.HKD","00763","SG9999001903.USD","LU1328277881.USD","LU0348735423.USD","LU0708995583.HKD","SG9999000459.SGD","LU0516423174.USD","603986","LU0289960550.SGD","BK1521","IE00BQXX3F31.USD","LU1282649067.USD","BK1190","LU0588545490.SGD","LU0972618739.USD","LU2237443895.HKD","LU1720050803.USD","LU0348805143.USD","03115","LU0188438112.USD","LU0047713382.USD","LU0608807946.USD","LU0882747503.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luye.cn","stockEarnings":[{"period":"1week","weight":0.0537},{"period":"1month","weight":0.0237},{"period":"3month","weight":-0.0442},{"period":"6month","weight":-0.203},{"period":"1year","weight":-0.4194},{"period":"ytd","weight":-0.2117}],"compareEarnings":[{"period":"1week","weight":0.0355},{"period":"1month","weight":0.0449},{"period":"3month","weight":0.0158},{"period":"6month","weight":-0.0153},{"period":"1year","weight":0.036},{"period":"ytd","weight":0.0148}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"绿叶制药集团有限公司是一家主要从事药品的开发、生产、推广及销售的公司。该公司经营四个分部,包括肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和中枢神经系统药物分部。肿瘤药物分部提供力扑素、博优诺、百拓维、希美纳及米美欣等药品。心血管系统药物分部提供血脂康、欧开及麦通纳等药品。消化与代谢药物分部提供贝希等药品。中枢神经系统药物分部提供思瑞康、若欣林、瑞可妥、美比瑞及金悠平等药品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.024212},{"month":2,"riseRate":0.333333,"avgChangeRate":0.016158},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.022436},{"month":4,"riseRate":0.5,"avgChangeRate":-0.006455},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.020854},{"month":6,"riseRate":0.333333,"avgChangeRate":0.018146},{"month":7,"riseRate":0.666667,"avgChangeRate":0.027172},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.036471},{"month":9,"riseRate":0.583333,"avgChangeRate":0.045957},{"month":10,"riseRate":0.5,"avgChangeRate":-0.00637},{"month":11,"riseRate":0.5,"avgChangeRate":0.024651},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.012685}],"exchange":"SEHK","name":"绿叶制药","nameEN":"LUYE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿叶制药,02186,绿叶制药股票,绿叶制药股票老虎,绿叶制药股票老虎国际,绿叶制药行情,绿叶制药股票行情,绿叶制药股价,绿叶制药股市,绿叶制药股票价格,绿叶制药股票交易,绿叶制药股票购买,绿叶制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}